Literature DB >> 12098304

An efficient route for the preparation of a 21-fluoro progestin-16 alpha,17 alpha-dioxolane, a high-affinity ligand for PET imaging of the progesterone receptor.

Dange Vijaykumar1, Wang Mao, Karen S Kirschbaum, John A Katzenellenbogen.   

Abstract

Two different synthetic routes were explored for the synthesis of fluoro furanyl norprogesterone (FFNP) 1, a high-affinity ligand for the progesterone receptor (PgR) that is being developed as a PET imaging agent for PgR-positive breast cancer. Both approaches proceed through a key intermediate, triol 5. The first approach, starting from keto-ketal 2, employed a dioxenyl group as a synthon for installing a corticosteroid side chain in keto-alcohol 4. The second approach, starting from propargylic acetate 12b, involved the application of a two-step method, a Pd(II)-catalyzed oxidative rearrangement followed by a base-catalyzed acetate rearrangement of the intermediate unsaturated acetate 13b, to generate the requisite corticosteroid side chain in keto-acetate 14b. This intermediate was further elaborated to the final product 1 via efficient dihydroxylation with potassium permangnate, furan acetalization with scandium triflate, and mesylation and fluorination reactions. The palladium-catalyzed route is considerably more efficient than the dioxene approach for the synthesis of key intermediate triol 5, and the scandium triflate-catalyzed acetalization, in particular, led to a considerable improvement in the overall yield of the endo furan acetal alcohol 16a. This route provides a major improvement in the overall yield of the final progestin target, FFNP 1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12098304     DOI: 10.1021/jo020190r

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  11 in total

1.  Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.

Authors:  Amy M Fowler; Szeman Ruby Chan; Terry L Sharp; Nicole M Fettig; Dong Zhou; Carmen S Dence; Kathryn E Carlson; M Jeyakumar; John A Katzenellenbogen; Robert D Schreiber; Michael J Welch
Journal:  J Nucl Med       Date:  2012-06-05       Impact factor: 10.057

2.  Synthesis and photochemical transformation of 3β,21-dihydroxypregna-5,7-dien-20-one to novel secosteroids that show anti-melanoma activity.

Authors:  Michal A Zmijewski; Wei Li; Jianjun Chen; Tae-Kang Kim; Jordan K Zjawiony; Trevor W Sweatman; Duane D Miller; Andrzej T Slominski
Journal:  Steroids       Date:  2010-11-09       Impact factor: 2.668

3.  Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies.

Authors:  Dong Zhou; Terry L Sharp; Nicole M Fettig; Hsiaoju Lee; Jason S Lewis; John A Katzenellenbogen; Michael J Welch
Journal:  Nucl Med Biol       Date:  2008-06-30       Impact factor: 2.408

4.  Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16alpha-[18F]fluoroestradiol (FES), [18F]fluoro furanyl norprogesterone (FFNP), and 16beta-[18F]fluoro-5alpha-dihydrotestosterone (FDHT) as radiopharmaceuticals.

Authors:  Dong Zhou; Mai Lin; Norio Yasui; Mohammed H Al-Qahtani; Carmen S Dence; Sally Schwarz; John A Katzenellenbogen
Journal:  J Labelled Comp Radiopharm       Date:  2014-02-17       Impact factor: 1.921

5.  Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.

Authors:  Farrokh Dehdashti; Richard Laforest; Feng Gao; Rebecca L Aft; Carmen S Dence; Dong Zhou; Kooresh I Shoghi; Barry A Siegel; John A Katzenellenbogen; Michael J Welch
Journal:  J Nucl Med       Date:  2012-02-13       Impact factor: 10.057

6.  Determination of binding affinity of molecular imaging agents for steroid hormone receptors in breast cancer.

Authors:  Kelley Salem; Manoj Kumar; Kyle C Kloepping; Ciara J Michel; Yongjun Yan; Amy M Fowler
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

7.  Mechanism of 17α,20-Lyase and New Hydroxylation Reactions of Human Cytochrome P450 17A1: 18O LABELING AND OXYGEN SURROGATE EVIDENCE FOR A ROLE OF A PERFERRYL OXYGEN.

Authors:  Francis K Yoshimoto; Eric Gonzalez; Richard J Auchus; F Peter Guengerich
Journal:  J Biol Chem       Date:  2016-06-23       Impact factor: 5.157

Review 8.  Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer.

Authors:  Amy M Fowler; Amy S Clark; John A Katzenellenbogen; Hannah M Linden; Farrokh Dehdashti
Journal:  J Nucl Med       Date:  2016-02       Impact factor: 10.057

9.  Sensitivity and Isoform Specificity of 18F-Fluorofuranylnorprogesterone for Measuring Progesterone Receptor Protein Response to Estradiol Challenge in Breast Cancer.

Authors:  Kelley Salem; Manoj Kumar; Yongjun Yan; Justin J Jeffery; Kyle C Kloepping; Ciara J Michel; Ginny L Powers; Aparna M Mahajan; Amy M Fowler
Journal:  J Nucl Med       Date:  2018-07-20       Impact factor: 10.057

10.  Progesterone-targeted magnetic resonance imaging probes.

Authors:  Taryn R Townsend; Georgette Moyle-Heyrman; Preeti A Sukerkar; Keith W MacRenaris; Joanna E Burdette; Thomas J Meade
Journal:  Bioconjug Chem       Date:  2014-07-25       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.